Various aliphatic N-acyl derivatives and an N-phthalidyl derivative of the model compound N- benzyloxycarbonyl-glycyl- l - prolineamide (Z-Gly-ProNH 2) were synthesized to assess their suitability as prodrug forms for the C-terminal prolineamide residue occurring in several peptides (e.g. TRH) with the aim of protecting the peptide against prolyl endopeptidase in the gut prior to absorption. Whereas Z-Gly-ProNH 2 was rapidly hydrolyzed in a rabbit gut homogenate, used as a source of prolyl endopeptidase, the N-acyl derivatives were found to afford protection by a factor of 1.5–6. The stability of the N-acyl derivatives in the gut homogenate decreased with increasing chain length within the acyl group. The N-phthalidyl derivative, on the other hand, degraded even faster than the parent compound. The derivatives were all converted quantitatively into the parent peptide in human plasma solutions via hydrolysis catalyzed by non-specific plasma esterases. The results suggest that by appropriate N-acylation it may be feasible to improve the stability of a C-terminal prolineamide moiety toward prolyl endopeptidase. The combination of increased stability in the intestine and higher lipophilicity of the N-acyl prodrugs might render it possible to improve the delivery characteristics of peptides containing a C-terminal prolineamide moiety.